The etiology of multiple myeloma (MM) is poorly understood. Summary data from genome-
wide association studies (GWASs) of multiple phenotypes can be exploited in a Mendelian …

Multiple myeloma (MM) is a plasma cell malignancy with a significant heritable basis.
Genome-wide association studies have transformed our understanding of MM …

A sizeable fraction of multiple myeloma (MM) is expected to be explained by heritable
factors. Genome-wide association studies (GWAS) have successfully identified a number of …

Background While genome-wide association studies (GWAS) of multiple myeloma (MM)
have identified variants at 23 regions influencing risk, the genes underlying these …

Although common risk alleles for multiple myeloma (MM) were recently identified, their
contribution to familial MM is unknown. Analyzing 38 familial cases identified primarily by …

Multiple myeloma (MM) is the second most common blood malignancy. Epidemiological
family studies going back to the 1920s have provided evidence for familial aggregation …

So far, 23 germline susceptibility loci have been associated with multiple myeloma (MM)
risk. It is unclear whether the genetic variation associated with MM susceptibility also …

Background: Genetic background plays a role in multiple myeloma susceptibility. Several
single-nucleotide polymorphisms (SNP) associated with genetic susceptibility to multiple …

Genome-wide association studies (GWAS) have transformed our understanding of
susceptibility to multiple myeloma (MM), but much of the heritability remains unexplained …

Multiple myeloma (MM) is one of the most common hematological malignancies, accounting
for 20% of all newly diagnosed hematological cancers [1]. The most recent data from Cancer …